Gracell Biotechnologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch GRCL and buy or sell other stocks, options, and ETFs commission-free!

About GRCL

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer. The company's therapy offers cellular therapeutics for the patients suffered from hematological malignancy, solid tumor or degenerative disease, enabling healthcare providers to cure their patients and improve their lives. 

CEO
Wei Cao, PhD
CEOWei Cao, PhD
Employees
Employees
Headquarters
Suzhou, Shanghai
HeadquartersSuzhou, Shanghai
Founded
2017
Founded2017
Employees
Employees

GRCL Key Statistics

Market cap
983.25M
Market cap983.25M
Price-Earnings ratio
-10.08
Price-Earnings ratio-10.08
Dividend yield
Dividend yield
Average volume
930.52K
Average volume930.52K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$10.44
52 Week high$10.44
52 Week low
$1.40
52 Week low$1.40
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.